RADIOTHERAPY RESPONSE IN ADVANCED STAGE OF CERVICAL CANCER TYPES OF HISTOPATHOLOGY SQUAMOS CELL CARCINOMA AND ADENOCARCINOMA

Natasha Bharat Sindunata; Eka Indah Pratiwi; arlavinda asmara lubis

doi:10.32532/jori.v15i1.158

RADIOTHERAPY RESPONSE IN ADVANCED STAGE OF CERVICAL CANCER TYPES OF HISTOPATHOLOGY SQUAMOS CELL CARCINOMA AND ADENOCARCINOMA

Natasha Bharat Sindunata, Eka Indah Pratiwi, arlavinda asmara lubis

Sari

Background: Cervical cancer is a malignancy that occurs on the cervix, and it is the most common cancer in the world. According by GLOBOCAN in 2020, cervical cancer ranks seventh globally. The main management of advanced cervical cancer is using radiotherapy. The problem that occurs is the need for radiation for advanced cervical cancer patiens while there is still a lack of availability of radiotherapy equipment, causing under treatment management.

Objective: To prove that the response to radiotherapy in patients with advanced cervical cancer types of histopathology squamous cell carcinoma is better than adenocarcinoma in Ulin General Hospital, Banjarmasin

Methods: The study used an analytic observational design with a cross sectional approach. The sample was taken over the time span during the study from January 2021 to December 2022 and was taken by total sampling.

Results: The total sample was 128 cervical cancer patients with 91 squamous cell carcinoma samples and 37 adenocarcinoma samples. After conducting a chi-square analysis between several variables and response to therapy, a significant relationship was found between histopathology and response to therapy, which concluded that cervical cancer with histopathology of squamous cell carcinoma is more radiosensitive than adenocarcinoma. This is due to the relationship between VEGF and radiation.

Conclusion: The response of radiotherapy is more sensitive in type of histopathology squamous cell carcinoma than in cervical cancer with type of histopathology adenocarcinoma.

Kata Kunci

Radiotherapy, Cervical Cancer, Adenocarcinoma, Squamous Cell Carcinoma

Teks Lengkap:

PDF (English)

Referensi

Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer : the Lancet Commision report. Lancet 2019; 393: 169-82.

Sung H, Ferlay J, Siegel R.L, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. ACS J. 2021; 71: p209-249.

Latifah HJ, Nurachmah, Elly, Hiryadi. Faktor yang Berkontribusi Terhadap Motivasi Menjalani Pemeriksaan Pap Smear Pasien Kanker Serviks di Poli Kandungan. Banjarmasin: Jurnal Keperawatan Suaka Insan. 2020; 5: p90-99.

Bohm ELJF, Hendy J, Hill R, Le Heron J, Mishra K, Trott K, et al. IAEA (International Atomic energy Agency). Radiation Biology : A Handbook For Teachers And Students. Training course Series. Vienna. 2017.

Andrijono, Purwoto G, Sekarutami SM, Handjari DR, Primariadewi, Nuhonni SA, et al. Kemenkes RI. Pedoman Nasional Pelayanan Kedokteran Kanker Serviks. Jakarta: Komite Penanggulangan Kanker Nasional. 2019.

Gunderson LL and Joel ET. Clinical Radiation Oncology. 3rd ed. Philadelphia : Elsivier Saunders, 2017; p 8-29.

Hopkins MP and Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol. 2016; 77(6):912–917.

Tinga DJ, Bouma J, Aalders JG. Patients with squamous cell versus adeno(squamous) carcinoma of the cervix, what factors determine the prognosis? Int J Gynecol Cancer. 2016; 2(2):83–91.

Kfouri CFA, Lombard W, Romania MCFN, Puls ML. Prognostic factors for response to chemotherapy in advanced tumors of the uterine cervix: the role of neoangiogenesis. Rev Col Bras Cir. 2019; 46(1): e2077.

Seiwert TY, Salama JK, Vokes EE. The concurrent chemoradiation paradigm--general principles. Nature clinical practice Oncology. 2017;4(2):86-100.

Nagy VM, Buiga R, Brie I, Nicolae T. Expression of VEGF, VEGFR, EGFR, COX-2 and MVD in cervical carcinoma, in relation with the response to radio-chemotherapy. Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. 2016;52(1):53-9.

Katanyoo K, Sanguanrungsirikul S, Manusirivithaya S. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer. Gynecologic Oncology. 2012;125(2):292–6.

Pringgowibowo J, Suardi D, Anwar R. Cervical cancer radiotherapy response in dr. Hasan Sadikin general center hospital. Indonesian Journal of Obstetrics & Gynecology Science. 2022;5(1):54–62.

Tokumo K, Kodama J, Seki N, Nakanishi Y, Miyagi Y, Kamimura S, et al. Different angiogenic pathways in human cervical cancers. Ginecol Oncol. 2017; 68(1):38-44.

Saijo Y, Furumoto H, Yoshida K, Nishimura M, Irahara M. Clinical Significance of Vascular Endothelial Growth Factor Expression and Microvessel Density in Invasive Cervical Cancer. The Journal of Medical Investigation. 2015; (62): 154-160.

Hu X, Liu H, Ye M, Zhu X. Prognostic value of microvessel density in cervical cancer. Cancer Cell Int. 2018; 18: 152.

DOI: https://doi.org/10.32532/jori.v15i1.158 <